Encore Wire has blown out recent expectations and analysts are moving estimates higher.

pubblicato il: 23/03/2012 - 20:26

If you find yourself rushing to take down an ad that could be interpreted as making light of rape, you?re doing internet marketing wrong. That?s the harsh lesson Belvedere Vodka is learning today. Right here at Forbes, Kashmir Hill reports on the offending ad: A terrified woman being grabbed by a gleeful man with a ...

pubblicato il: 23/03/2012 - 20:26

Solar power may be not be best way to reduce the environmental impact of sprawling data centers built by companies such as and Facebook, James Hamilton, an Amazon vice president and distinguished engineer wrote on his personal blog last Saturday. "If we had $x dollars to invest in lowering datacenter environmental impact and the marketing ...

pubblicato il: 23/03/2012 - 20:26

The film earned $155 million at the box office this weekend making it the third best opening of all time.

pubblicato il: 26/03/2012 - 17:56

Vorapaxar, the novel antiplatelet agent from , appears to effectively reduce cardiovascular death and ischemic events in patients with MI, ischemic stroke, or peripheral vascular disease, but its potential utility is clouded by bleeding complications, including intracranial hemorrhage. Results from the??TRA 2P-TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial were ...

pubblicato il: 24/03/2012 - 14:26

This clear, five-step process, which combines volume and chart analysis, has proven highly effective in identifying stocks that went on to become market leaders. In reviewing many of the interviews that are conducted in the MoneyShow.com video studio, I am often struck by how many traders and analysts do not find volume important. Though I have no doubt that it is possible to be a successful trader or investor without looking at volume, I think they are ignoring an important piece of data. Often times, unusual volume patterns can alert the investor to stocks that will be future market leaders. As I indicated last summer, the volume surge seen in Grupo Financiero Galicia S.A. (GGAL) on August 2, 2010 caught my attention. The volume of 5.7 million shares was over ten times the daily average. GGAL soon closed above major weekly resistance and surged from $6.98 to over $16 in the next five months. This was the also the case in October 2011 when homebuilding stocks surged on heavy volume (see "Big Volume Is Bullish for Homebuilders"). At the time, few thought that the housing market had bottomed, but now that is almost becoming the consensus view. Many of the homebuilding stocks have doubled since October. During the recent World Money Show in Orlando, I gave an interview about the importance of volume in my analysis, and I explained why the entry level can be such an important factor in successful investing and trading. (See that interview here.) I thought it might be helpful to break down the process I use in selecting and recommending stocks from my high-volume scan into five steps. The process starts with isolating those stocks that show a significant increase in volume. Increasing volume is what can push a stock higher and turn it into a market leader.

pubblicato il: 24/03/2012 - 14:26

Jerry McQuire built his business using brute force; identifying a trigger event has been hit or miss. The amount of heavy lifting required to find enough of these clues to fill a salesperson's pipeline is daunting. To survive Sales needs to sell smarter; social tools and a 7 step approach can be today's "Help me help you".

pubblicato il: 24/03/2012 - 17:25

Obamacare was signed into law on March 23, 2010. This week, the White House organized activists in an effort to tout the law's alleged benefits: seniors on Monday, women on Tuesday, young adults and kids on Wednesday, health costs on Thursday, and pre-existing conditions on Friday. So let's go through and discuss what the law actually does in these areas.

pubblicato il: 24/03/2012 - 17:25

I agree, there are different ways that you can look at a company. But I think that this Gizmodo piece The Case Against Google errs in a very important manner, in that it never even considers the most important way we ought to think about the company: as a company, a profit generating entity. Yes, ...

pubblicato il: 24/03/2012 - 17:25

Two of my recent posts* have addressed the drivers of high health care costs in the U.S. I?ve received a lot of comments, for which I?m grateful, as this is meant to be a conversation. Many of the comments have come from the medical community: doctors, heads of medical practice groups, the AMA, and service ...

pubblicato il: 24/03/2012 - 15:24